Lv51
1098 积分 2023-05-17 加入
Coronary flow reserve in patients with dilated cardiomyopathy
39分钟前
已完结
Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation
1个月前
已完结
SPIROMICS HF: Rationale, Design, and Reproducibility of Measures
5个月前
已完结
The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient
5个月前
已关闭
Treatment With Myosin Inhibitor in a Patient With Symptomatic Hypertrophic Cardiomyopathy With Isolated Right Ventricular Obstruction
5个月前
已完结
Heterogeneous Dysregulation of Myosin Super-Relaxation and Energetics in Hypertrophic Cardiomyopathy
6个月前
已完结
SPOP Is a Key Trigger of Pathological Cardiac Hypertrophy and Heart Failure
6个月前
已完结
Myosin Mayhem: Losing (or Gaining) Its Chill in Hypertrophic Cardiomyopathy
6个月前
已完结
High Sensitivity Troponin for Contemporary Risk Stratification in Wild-Type ATTR Amyloidosis
9个月前
已完结
Letter by Zhang and Zeng Regarding Article, “Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry”
10个月前
已完结
皖公网安备34019202002308
